AIP
KERX

Ameritas Investment Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Ameritas Investment Partners’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,631
Closed -$26K – 3017
2018
Q3 		$26K Hold
7,631
– – ﹤0.01% 2385
2018
Q2 		$29K Hold
7,631
– – ﹤0.01% 2305
2018
Q1 		$31K Hold
7,631
– – ﹤0.01% 2199
2017
Q4 		$35K Buy
7,631
+1,479
+24% +$8.15K ﹤0.01% 2133
2017
Q3 		$44K Hold
6,152
– – ﹤0.01% 1977
2017
Q2 		$44K Hold
6,152
– – ﹤0.01% 2002
2017
Q1 		$38K Buy
+6,152
New +$33.7K ﹤0.01% 2025

Ameritas Investment Partners's KERX Position: Q4 2018 in Review

Ameritas Investment Partners sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 7,631 shares — an estimated $26K sold.

Ameritas Investment Partners first reported a position in KERX in Q1 2017 and held it in 7 quarters. The position peaked at $44K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Ameritas Investment Partners reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 7,631 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $26K.
  • Ameritas Investment Partners first reported a position in Keryx Biopharmaceuticals Inc in Q1 2017 and held it in 7 quarters.
  • Ameritas Investment Partners's Keryx Biopharmaceuticals Inc position peaked at $44K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Ameritas Investment Partners's 13F filing for Q4 2018, filed 12 Feb 2019.